Contact Us
CN EN
News Center

Frost & Sullivan Releases the 2026 White Book on the Development of Synthetic Biology Industry; Bestzyme Selected as a Benchmark Case

Release time:2026.11.16 | Bestzyme


Recently, Frost & Sullivan officially released the White Book on the Development of Synthetic Biology Industry in 2026. The white Book systematically reviews the current state of play, technological progress, application landscape and future trends of the synthetic biology industry worldwide and in China, and examines the pathways through which the sector is moving beyond isolated technologies toward the deep integration of platforms, data and industrialization.



An English edition has also been published on Frost & Sullivan's global official website. Reaching more than 500 media outlets worldwide and generating over 900 published news links, the white paper helps Chinese synthetic biology enterprises enhance their international brand image and advance their global footprint.


Bestzyme Selected as a Benchmark Case

Bestzyme was invited to participate in the white paper's case study program and has been featured as an exemplary benchmark enterprise in the synthetic biology sector. The white paper notes that Bestzyme, the industrial synthetic biology platform under GenScript Biotech, has built a closed technology loop spanning enzyme R&D, functional protein design, fermentation process development, large-scale manufacturing and cross-sector applications. The company operates more than six industrial-grade bacterial and fungal expression platforms and has established an automated bio-manufacturing base with an annual production capacity exceeding 150,000 tonnes.


From grain processing, food and nutrition, to animal nutrition and health, home care and textiles, Bestzyme continues to bring synthetic biology technologies from the laboratory to industrial-scale applications, enabling green bio-manufacturing across an expanding range of industrial scenarios.


Being featured in this white paper recognizes Bestzyme's technology platform and industrialization capabilities. Going forward, Bestzyme will continue to uphold its mission of "using biotechnology to promote health for people and nature," leading bio-innovation and catalyzing a greener future.


For the full content, please refer to the Chinese and English bilingual editions of Frost & Sullivan's White Book on the Development of the Synthetic Biology Industry in 2026.